Topiramate Tablet
Product Images NDC 50090-6895

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-6895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01)
Chemical structure of topiramate, showing its molecular arrangement including multiple oxygen atoms, sulfur dioxide amine group, and tert-butyl groups attached to a six-membered ring.*
FDA Label Image

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)

Topi (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02)
A line graph depicting cumulative rates for time to first seizure over a 500-day period for two Topiramate dosage groups: 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative rates for time to first seizure. The 50 mg/day group shows higher cumulative seizure rates compared to the 400 mg/day group, with a significant p-value of 0.0002.*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency(studies 10 And 11 For Adults And Adolescents) (Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03)
A bar chart comparing changes from baseline to double-blind phase in average weekly migraine period days (± SEM) for placebo and Topamax (topiramate) at doses 50 mg/day, 100 mg/day, and 200 mg/day across two studies (Study 10 and Study 11). The chart shows greater reductions in migraine days with increasing Topamax doses compared to placebo, with statistical significance indicated at various dose levels.*
FDA Label Image

Label Image (Lbl500906895)

Label Image (Lbl500906895)
Label for Topiramate 100 mg oral tablets, manufactured by A-S Medication Solutions. The label indicates 90 orange tablets per container with storage instructions to keep between 60 to 77 degrees Fahrenheit and protect from moisture. It includes product and lot numbers, along with a barcode and NDC 50090-6895-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.